Authenticity and personal connection are key in Marvel auditions to secure coveted roles. Marvel is reportedly eyeing a ...
On August 15, Tevogen Bio entered into a definitive agreement for a $6 million Series C Preferred Stock investment (“Series C”). The shares of the Series C have a 7.5% annual dividend and are ...
What you should knowEagles fans swarmed the streets to take in the Super Bowl victory parade, camping out all day as the team ...
IN8bio is accelerating patient enrollment in the INB-100 program and expects to complete enrollment of the expansion cohort in 2025. The company’s FDA discussions confirmed that relapse-free survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results